Psychoses associated with bupropion treatment
- 1 December 1985
- journal article
- research article
- Published by American Psychiatric Association Publishing in American Journal of Psychiatry
- Vol. 142 (12) , 1459-1462
- https://doi.org/10.1176/ajp.142.12.1459
Abstract
The authors describe the development of acute psychoses in four patients treated with bupropion, a unicyclic aminoketone antidepressant. In two of the cases the psychoses seemed to be affected by dose. The mechanism responsible for the psychotic reactions is unclear, although it may involve perturbation of dopaminergic systems. On the basis of their experience, the authors offer recommendations regarding the clinical use of bupropion.This publication has 11 references indexed in Scilit:
- Second-Generation AntidepressantsPsychiatric Clinics of North America, 1984
- FAILURE OF BUPROPION TO AFFECT PROLACTIN OR GROWTH-HORMONE IN MAN1983
- REVIEW OF PLACEBO-CONTROLLED TRIALS WITH BUPROPION1983
- COMPARISON OF BUPROPION ALONE AND WITH HALOPERIDOL IN SCHIZO-AFFECTIVE DISORDER, DEPRESSED TYPE1983
- ANTI-DEPRESSANT RESPONSE AND PLASMA-CONCENTRATIONS OF BUPROPION1983
- BUPROPION AND AMITRIPTYLINE IN THE TREATMENT OF DEPRESSED-PATIENTS1983
- Perceptual changes with bupropion, a novel antidepressantAmerican Journal of Psychiatry, 1982
- Selective and Nonselective Monoamine Oxidase InhibitorsArchives of General Psychiatry, 1982
- Influence of bupropion HCL (Wellbatrin®), a novel antidepressant, on plasma levels of prolactin and growth hormone in man and ratLife Sciences, 1979
- The Behavioral Toxicity of Monoamine Oxidase-lnhibiting AntidepressantsPublished by Elsevier ,1977